Company registration number 03912226 (England and Wales)
MYCOMARKETING LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
A9 Accountancy Limited
Chartered Accountants
Elm House
Cradlehall Business Park
Inverness
IV2 5GH
MYCOMARKETING LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
-
0
4,304
Current assets
Stocks
-
442
Debtors
5
2,408
16,384
Cash at bank and in hand
63,414
13,430
65,822
30,256
Creditors: amounts falling due within one year
6
(8,247)
(10,708)
Net current assets
57,575
19,548
Total assets less current liabilities
57,575
23,852
Creditors: amounts falling due after more than one year
7
(86,975)
(93,098)
Net liabilities
(29,400)
(69,246)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(29,500)
(69,346)
Total equity
(29,400)
(69,246)
MYCOMARKETING LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JANUARY 2026
31 January 2026
- 2 -

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 24 October 2026 and are signed on its behalf by:
Ms Jane Dick
Director
Company registration number 03912226 (England and Wales)
MYCOMARKETING LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
1
Accounting policies
Company information

Mycomarketing Limited is a private company limited by shares incorporated in England and Wales. The registered office is 52 The Highway, Great Staughton, St. Neots, England, PE19 5DA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The directors have reviewed the company's financial position, available cash resources and liabilities falling due. Having considered these matters, the directors consider that the company has adequate resources to meet its obligations as they fall due for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.true

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of value added tax and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% reducing balance
Fixtures and fittings
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

MYCOMARKETING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

MYCOMARKETING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 5 -
1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

 

Interest expense is recognised on the basis of the effective interest method and is included in the interest payable and similar charges.

 

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
MYCOMARKETING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 6 -
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 February 2025
36,077
2,078
38,155
Disposals
(36,077)
(2,078)
(38,155)
At 31 January 2026
-
0
-
0
-
0
Depreciation and impairment
At 1 February 2025
32,360
1,491
33,851
Eliminated in respect of disposals
(32,360)
(1,491)
(33,851)
At 31 January 2026
-
0
-
0
-
0
Carrying amount
At 31 January 2026
-
0
-
0
-
0
At 31 January 2025
3,717
587
4,304
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
-
0
12,329
Other debtors
1,977
3,439
Prepayments and accrued income
431
616
2,408
16,384
6
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans
6,932
6,932
Trade creditors
-
0
1,937
Taxation and social security
-
0
589
Other creditors
1,315
1,250
8,247
10,708
7
Creditors: amounts falling due after more than one year
2026
2025
£
£
Bank and other loans
86,975
93,098
MYCOMARKETING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
8
Directors' transactions

 

Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Director Loan
-
3,297
1,200
(3,000)
1,497
3,297
1,200
(3,000)
1,497
This was repaid post year-end.
2026-01-312025-02-01falsefalsefalse24 October 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMs Jane DickMs Susan WhitingMs Susan Whiting039122262025-02-012026-01-31039122262026-01-31039122262025-01-3103912226core:PlantMachinery2026-01-3103912226core:FurnitureFittings2026-01-3103912226core:PlantMachinery2025-01-3103912226core:FurnitureFittings2025-01-3103912226core:WithinOneYear2026-01-3103912226core:WithinOneYear2025-01-3103912226core:CurrentFinancialInstrumentscore:WithinOneYear2026-01-3103912226core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3103912226core:Non-currentFinancialInstrumentscore:AfterOneYear2026-01-3103912226core:Non-currentFinancialInstrumentscore:AfterOneYear2025-01-3103912226core:ShareCapital2026-01-3103912226core:ShareCapital2025-01-3103912226core:RetainedEarningsAccumulatedLosses2026-01-3103912226core:RetainedEarningsAccumulatedLosses2025-01-3103912226bus:Director12025-02-012026-01-3103912226core:PlantMachinery2025-02-012026-01-3103912226core:FurnitureFittings2025-02-012026-01-31039122262024-02-012025-01-3103912226core:PlantMachinery2025-01-3103912226core:FurnitureFittings2025-01-31039122262025-01-3103912226core:CurrentFinancialInstruments2026-01-3103912226core:CurrentFinancialInstruments2025-01-3103912226bus:PrivateLimitedCompanyLtd2025-02-012026-01-3103912226bus:SmallCompaniesRegimeForAccounts2025-02-012026-01-3103912226bus:FRS1022025-02-012026-01-3103912226bus:AuditExemptWithAccountantsReport2025-02-012026-01-3103912226bus:Director22025-02-012026-01-3103912226bus:CompanySecretary12025-02-012026-01-3103912226bus:FullAccounts2025-02-012026-01-31xbrli:purexbrli:sharesiso4217:GBP